Minima Stent System Post- Approval Study (PAS)

Exclusion Criteria

• •Active bloodstream infection requiring antibiotic therapy within 3 days prior to stent implantation
• •History of or active endocarditis (active treatment with antibiotics) within 180 days prior to stent implantation
• •Aortic or pulmonary artery aneurysm in the location targeted for treatment
• •Body weight \< 1.5 kg
• •Anatomic location of lesion judged by the investigator to not lend to the safe placement of a stent
• •Target vessels larger or smaller than the Minima System balloon size ranges
• •Known genetic syndrome known to be associated with vasculopathies such as but not limited to Williams syndrome, Loeys-Dietz syndrome, etc
• •Clinical scenario requiring that more than one vessel needs stent implantation at the time of the trial procedure.
• •Currently participating in an investigational drug study or another device study
• •Major or progressive non-cardiac disease resulting in a life expectancy of less than six months
• •Known hypersensitivity to aspirin or heparin and cannot be treated with other antiplatelet and/or antithrombotic medications
• •Known hypersensitivity to cobalt-chromium or contrast media that cannot be adequately premedicated